AbbVie Scores HCV First Under UK’s Early Access Scheme

 
• By Neena Brizmohun and Maureen Kenny
Hep C virus
AbbVie's HCV treatment has received a positive scientific opinion under the UK's early access to medicines scheme • Source: Shutterstock

More from Market Access

More from Pink Sheet